In recent years, the landscape of Collateralized Loan Obligation BB-rated debt has undergone a quiet but profound ...

Live Oak Bancshares, Inc. is rated a Buy with robust fundamentals & solid performance in the macroeconomic environment. Read ...

Elfabrio (R) (pegunigalsidase alfa for injection) is an enzyme replacement therapy indicated for the longterm treatment of adult patients with a confirmed diagnosis of Fabry disease (deficiency of ...

Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, today announced FDA approval of a Phase II clinical trial ...

From AI search and commerce media to measurement and consolidation, we share the seven trends that will shape marcoms over ...

Following last week’s release, Apple is rolling out macOS 26.1 beta 4 for developers, as well as the public beta. Here’s what to expect from the update. Aside from the usual bug fixes and performance ...

Following yesterday’s release of macOS Tahoe 26.1 developer beta 3, Apple has just released the equivalent public beta. Here’s what to expect from macOS Tahoe 26.1. Apple seems to have set macOS Tahoe ...

Get ready for new wild disasters in an all-new location, “9-1-1” is headed to Tennessee in the latest entry in the TV franchise, “9-1-1: Nashville.” Like the flagship series, “9-1-1: Nashville” ...

We have you covered with our full thoughts of this hour. For those, check out our Chicago PD Season 13 Episode 1 Review. In the meantime, here’s a scene-by-scene recap of Consequences. We open with ...

New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil ...

The emerging field of AI orchestration just got an additional boost of confidence with the alpha release of LangChain’s two flagship platforms, LangGraph and LangChain version 1.0. Graduating to a 1.0 ...